MRC Myobrace Interceptive Class i3

MRC’s Myobrace appliances correct myofunctional habits and improve facial development in children without braces by training proper tongue positioning, nose breathing, and oral muscle function. The Myobrace Interceptive Class III targets early treatment of Class III malocclusion by promoting upper arch development and limiting excessive lower jaw growth. Designed for children ages 5-8, it uses DynamiCore to assist in positioning the tongue correctly.

In stock
SKU
SBMR02107
Grouped product items
Product Name Qty
MRC Myobrace Interceptive Class i3- Small - MBi3S
₹5,490.00
Out of stock
MRC Myobrace Interceptive Class i3- Medium/Regular - MBi3M
₹5,490.00
MRC Myobrace Interceptive Class i3 Large - MBi3L
₹5,490.00
MRC Myobrace Interceptive Class i3 is available to buy in increments of 1

Contact us for sales assistance from our Biomedical Engineer.

Prashanth Reddy V | Senior Sales Executive

+91 9063507429

[email protected]

Features:

  • Dynamicore™ with Frankel Cage: Aids in widening the upper jaw, creating more space for the tongue (Frankel Cage not included in i-3n model).
  • Small breathing holes and dual arch form: Designed to prevent mouth breathing, commonly seen in Class III cases.
  • Tongue guard and tongue elevators: Encourage proper tongue positioning, helping to limit unwanted lower jaw growth.

INDICATION:

  • Class III malocclusion correction for the growing children- (Age: 5 to 8 years)

ADVANTAGES:

  • Improves arch form 
  • Tongue resting position
  • Correct swallowing patterns are established
  • Provides good dental alignment
Technical Details
Technical Specification
  • Country Of Origin: Australia
  • Manufacturer: Myofunctional Research Co.
  • Available in 3 sizes:
    • Small 
    • Medium
    • Large
  • Pack Of 1
Write Your Own Review
You're reviewing:MRC Myobrace Interceptive Class i3

Contact us for sales assistance from our Biomedical Engineer.

Prashanth Reddy V | Senior Sales Executive

+91 9063507429

[email protected]

WA button WA button
Copyright © 2023-present SignelbioMedical, Inc. All rights reserved.